Surface crosslinking for delayed release of proxyphylline from PHEMA hydrogels
- PMID: 17825507
- DOI: 10.1016/j.ijpharm.2007.07.032
Surface crosslinking for delayed release of proxyphylline from PHEMA hydrogels
Abstract
Delayed release systems find applications in chronotherapeutics and colon-specific delivery. They have also been considered suitable carriers for the oral delivery of peptides and proteins. In prior work, our research group has reported surface crosslinking as an effective technique to modify drug release profiles for poly(vinyl alcohol) (PVA) hydrogels, reducing the early burst effect in particular. Here, we demonstrate the feasibility of delayed release of proxyphylline from poly(2-hydroxyethyl methacrylate) (PHEMA) hydrogels via surface crosslinking. Studies on in vitro drug release and the morphology changes of PHEMA hydrogels during swelling and drug release showed that the highly surface crosslinked layers and the ruptures occurring in these layers during swelling were likely responsible for the delayed release. In addition, the initial burst was significantly reduced or even eliminated from the drug release profile for PHEMA to achieve near zero-order release by judicious selection of two surface crosslinking parameters: crosslinking reagent concentration and exposure time used for the surface crosslinking treatment.
Similar articles
-
Modifying the release of proxyphylline from PVA hydrogels using surface crosslinking.Int J Pharm. 2008 Feb 12;349(1-2):144-51. doi: 10.1016/j.ijpharm.2007.08.007. Epub 2007 Aug 12. Int J Pharm. 2008. PMID: 17875374
-
Effect of the crosslinking degree and the nickel salt load on the thermal decomposition of poly(2-hydroxyethyl methacrylate) hydrogels and on the metal release from them.J Colloid Interface Sci. 2006 Mar 15;295(2):393-400. doi: 10.1016/j.jcis.2005.10.015. Epub 2005 Nov 8. J Colloid Interface Sci. 2006. PMID: 16288772
-
Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.Eur J Pharm Biopharm. 2012 May;81(1):149-58. doi: 10.1016/j.ejpb.2011.12.016. Epub 2012 Jan 2. Eur J Pharm Biopharm. 2012. PMID: 22233548
-
In situ gelling hydrogels for pharmaceutical and biomedical applications.Int J Pharm. 2008 May 1;355(1-2):1-18. doi: 10.1016/j.ijpharm.2008.01.057. Epub 2008 Feb 7. Int J Pharm. 2008. PMID: 18343058 Review.
-
Casein-based formulations as promising controlled release drug delivery systems.J Control Release. 2011 Aug 10;153(3):206-16. doi: 10.1016/j.jconrel.2011.02.010. Epub 2011 Feb 19. J Control Release. 2011. PMID: 21338636 Review.
Cited by
-
Subconjunctivally Implanted Hydrogels for Sustained Insulin Release to Reduce Retinal Cell Apoptosis in Diabetic Rats.Invest Ophthalmol Vis Sci. 2015 Dec;56(13):7839-46. doi: 10.1167/iovs.15-16998. Invest Ophthalmol Vis Sci. 2015. PMID: 26658505 Free PMC article.
-
Preparation and characterization of molecularly imprinted poly(hydroxyethyl methacrylate) microspheres for sustained release of gatifloxacin.J Mater Sci Mater Med. 2014 Jun;25(6):1461-9. doi: 10.1007/s10856-014-5191-7. Epub 2014 Mar 21. J Mater Sci Mater Med. 2014. PMID: 24652594
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous